Response rate with weekly epirubicin and docetaxel as neoadjuvant chemotherapy (NAC) for locally-advanced breast cancer (BC).

被引：0
|
作者：
Chen, SC
Chang, HK
Lin, YC
Leung, WM
Chang, JT
Cheung, YC
Hsueh, S
Lo, YF
Tsai, HP
Chen, MF
机构：
[1] Chang Gung Mem Hosp, Taipei 10591, Taiwan
[2] Breast Canc Study Grp, Taipei 10591, Taiwan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：99S / 99S
页数：1
相关论文
共 50 条
  • [31] NEOADJUVANT CHEMOTHERAPY (NAC) WITH DOCETAXEL AND LIPOSOME-ENCAPSULATED DOXORUBICIN IN LOCALLY ADVANCED HER2-BREAST CANCER (LABC)
    Merlano, M. C.
    Airoldi, M.
    Pedani, F.
    Contu, V.
    Margiotta, C.
    Fiore, J.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 102 - 102
  • [32] Unfavorable Pathological Complete Response Rate of Neoadjuvant Chemotherapy Epirubicin plus Taxanes for Locally Advanced Triple-negative Breast Cancer
    尹一
    张频
    徐兵河
    张柏林
    李青
    袁芃
    蔡瑞刚
    王佳玉
    王翔
    徐晓洲
    [J]. Current Medical Science, 2013, (02) : 262 - 265
  • [33] Unfavorable Pathological Complete Response Rate of Neoadjuvant Chemotherapy Epirubicin plus Taxanes for Locally Advanced Triple-negative Breast Cancer
    尹一
    张频
    徐兵河
    张柏林
    李青
    袁芃
    蔡瑞刚
    王佳玉
    王翔
    徐晓洲
    [J]. Journal of Huazhong University of Science and Technology(Medical Sciences), 2013, 33 (02) : 262 - 265
  • [34] Unfavorable pathological complete response rate of neoadjuvant chemotherapy epirubicin plus taxanes for locally advanced triple-negative breast cancer
    Yi Yin
    Pin Zhang
    Bing-he Xu
    Bai-lin Zhang
    Qing Li
    Peng Yuan
    Rui-gang Cai
    Jia-yu Wang
    Xiang Wang
    Xiao-zhou Xu
    [J]. Journal of Huazhong University of Science and Technology [Medical Sciences], 2013, 33 : 262 - 265
  • [35] Unfavorable pathological complete response rate of neoadjuvant chemotherapy epirubicin plus taxanes for locally advanced triple-negative breast cancer
    Yin, Yi
    Zhang, Pin
    Xu, Bing-he
    Zhang, Bai-lin
    Li, Qing
    Yuan, Peng
    Cai, Rui-gang
    Wang, Jia-yu
    Wang, Xiang
    Xu, Xiao-zhou
    [J]. JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2013, 33 (02) : 262 - 265
  • [36] Characterization of Tumor Heterogeneity as a Predictor of Response to Neoadjuvant Chemotherapy in Locally-Advanced Rectal Cancer
    Greenbaum, A.
    Martin, D.
    Bocklage, T.
    Lee, J.
    Ness, S.
    Rajput, A.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : S105 - S106
  • [37] Neoadjuvant epirubicin with or without sequential docetaxel in treatment of advanced breast cancer: assessment of pathological complete response and chemotherapy tolerability
    Ramirez-Torres, Nicolas
    Perez-Puentes, Ancizar
    Moctezuma-Meza, Christian
    Victoria-Ayala, Rosalia
    Ortiz-Rodriguez, Kenia
    Valenzuela-Martinez, Larissa A.
    Eugenia Ayala-Anzures, Maria
    [J]. CIRUGIA Y CIRUJANOS, 2019, 87 (01): : 59 - 68
  • [38] High pathologic complete response in her-2-positive locally advanced breast cancer(LABC) after primary systemic chemotherapy with weekly docetaxel and epirubicin
    Chen, Shin-Cheh
    Lin, Yung-Chang
    Chang, Hsien-Kun
    Hsueh, Swei
    Leung, Wai-Man
    Tsai, Chien-Sheng
    Lo, Yung-Feng
    Tsai, Hsiu-Pei
    Shen, Shih-Che
    Chen, Miin-Fu
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 96 - 96
  • [39] Phase II study of neoadjuvant therapy with epirubicin and docetaxel for women with locally advanced breast cancer.
    Holter, JL
    Tfayli, A
    Venkattapa, S
    Bova, A
    Howard, O
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 98S - 98S
  • [40] Neoadjuvant chemotherapy in locally advanced breast cancer
    Singh, G
    Singh, DP
    Gupta, D
    Muralikrishna, BV
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 1996, 61 (01) : 38 - 41
12345